ClinicalTrials.gov
ClinicalTrials.gov Menu

Safety and Tolerability of Transcranial Direct Current Stimulation (tDCS)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01148212
Recruitment Status : Completed
First Posted : June 22, 2010
Last Update Posted : February 8, 2011
Sponsor:
Information provided by:
Ludwig-Maximilians - University of Munich

Brief Summary:

Testing safety and tolerability of transcranial direct current stimulation (2 mA, 20 minutes) in four different protocols:

saline-soaked sponges electrode with electrode gel tap-water-soaked sponges tap-water-soaked-sponges + sham stimulation

Outcome measures are tolerability (comfort rating questionnaire), impedances, skin elasticity


Condition or disease
Best Comfort and Lowest Skin Irritation

Study Type : Observational
Actual Enrollment : 15 participants
Observational Model: Case-Only
Official Title: Safety and Tolerability of Transcranial Direct Current Stimulation (tDCS)
Study Start Date : June 2009
Actual Primary Completion Date : December 2010
Actual Study Completion Date : January 2011




Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years to 65 Years   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Sampling Method:   Probability Sample
Study Population
15 healthy volunteers
Criteria

Inclusion Criteria:

  • no neurological or psychiatric illness
  • written informed consent

Exclusion Criteria:

  • dermatologic diseases
  • medication with corticoids

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01148212


Locations
Germany
Ludwig-Maximilian-University, Dept. of Psychiatry
Munich, Germany, 80336
Sponsors and Collaborators
Ludwig-Maximilians - University of Munich
Investigators
Principal Investigator: Ulrich Palm, MD Ludwig-Maximilian-University
Study Chair: Frank Padberg, MD Ludwig-Maximilian-University

Responsible Party: Ulrich Palm, MD, Ludwig-Maximilian-University Munich
ClinicalTrials.gov Identifier: NCT01148212     History of Changes
Other Study ID Numbers: 10/2009
First Posted: June 22, 2010    Key Record Dates
Last Update Posted: February 8, 2011
Last Verified: January 2011